alloxan has been researched along with taxifolin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akash, MSH; Chohan, TA; Gilani, Z; Rehman, K; Waheed, I | 1 |
| Alay, M; Altuner, D; Atmaca, M; Bulut, S; Coban, A; Sakin, A; Sonmez, MG; Suleyman, B; Suleyman, H; Yazici, GN | 1 |
2 other study(ies) available for alloxan and taxifolin
| Article | Year |
|---|---|
Taxifolin prevents postprandial hyperglycemia by regulating the activity of α-amylase: Evidence from an in vivo and in silico studies.
Topics: Acarbose; Alloxan; alpha-Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Glucose; C-Reactive Protein; Catalytic Domain; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycoside Hydrolase Inhibitors; Lipase; Lipid Metabolism; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Quercetin; Rats | 2019 |
The effects of taxifolin on neuropathy related with hyperglycemia and neuropathic pain in rats: A biochemical and histopathological evaluation.
Topics: Alloxan; Animals; Antioxidants; Hyperglycemia; Male; Neuralgia; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Reactive Oxygen Species | 2022 |